DEVICE KITS SUPPLIED VIA "RISK-SHARING" ARRANGEMENTS PROTECTED FROM ANTI-KICKBACK RULES UNDER INSURANCE REFORM LAW SIGNED BY CLINTON
This article was originally published in The Gray Sheet
Device manufacturers that supply bundled medical products to health care providers as part of risk-sharing agreements are protected from anti-kickback penalties under health insurance reform legislation (HR 3103) signed into law by President Clinton Aug. 21.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.